SRRK Scholar Rock, Inc.

NASDAQ
$52.52

Scholar Rock, Inc. (SRRK) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.87 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.6% since its last earnings release on August 6, 2026.

Scholar Rock Reported In-line with Estimates
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.87)
Rev est $1.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $52.72

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Scholar Rock, Inc.

Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.

Sector

Healthcare

Industry

Biotechnology